Market Tracker

12/08 1:12pm ET

Cytokinetics Inc (NASDAQ:CYTK)

11.28
Delayed Data
As of 12:57pm ET
 +0.075 / +0.67%
Today’s Change
6.00
Today|||52-Week Range
12.98
+7.79%
Year-to-Date
No recent news for Cytokinetics Inc.

Today’s Trading

Previous close11.20
Today’s open11.20
Day’s range10.75 - 11.35
Volume70,061
Average volume (3 months)341,355
Market cap$457.8M
Dividend yield--
Data as of 12:57pm ET, 12/08/2016

Growth & Valuation

Earnings growth (last year)-136.59%
Earnings growth (this year)+78.18%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)-38.95%
P/E ratioNM
Price/Sales14.17
Price/Book6.52

Competitors

 Today’s
change
Today’s
% change
VSARVersartis Inc+0.05+0.39%
CTMXCytomX Therapeutics ...-0.15-1.24%
HSKAHeska Corp+0.97+1.43%
NERVMinerva Neuroscience...+0.15+1.18%
Data as of 1:11pm ET, 12/08/2016

Financials

Next reporting dateFebruary 7, 2017
EPS forecast (this quarter)-$0.41
Annual revenue (last year)$28.7M
Annual profit (last year)-$37.5M
Net profit margin-130.86%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert I. Blum
Chief Financial Officer, Secretary &
Executive VP
Barabari Sharon A. Surrey
Corporate headquarters
South San Francisco, California

Forecasts